Matinas BioPharma Holdings, Inc.

MTNB · NYSE · SIC 2834: Pharmaceutical Preparations
219
SEC Filings

Business Summary

PART I Background Matinas BioPharma Holdings, Inc. (Matinas or the Company) is a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using our lipid nanocrystal (LNC) platform delivery technology (the LNC Platform). Our lead product candidate is MAT2203 (oral amphotericin B), a highly potent antifungal drug which, by virtue of LNC delivery, has been made oral, safe, and well-tolerated for prolonged administration in patients with life-threatening invasive fung...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMTNBdiscussed_in_filing Artificial Intelligence
topic_mentionMTNBdiscussed_in_filing Cybersecurity
topic_mentionMTNBdiscussed_in_filing Trusted Computing
topic_mentionMTNBdiscussed_in_filing Blockchain & Crypto
topic_mentionMTNBdiscussed_in_filing Regulation
topic_mentionMTNBdiscussed_in_filing Healthcare & Bio
topic_mentionMTNBdiscussed_in_filing Platform & Ecosystem
topic_mentionMTNBdiscussed_in_filing Artificial Intelligence
topic_mentionMTNBdiscussed_in_filing Cybersecurity
topic_mentionMTNBdiscussed_in_filing Trusted Computing
topic_mentionMTNBdiscussed_in_filing Blockchain & Crypto
topic_mentionMTNBdiscussed_in_filing Regulation
topic_mentionMTNBdiscussed_in_filing Healthcare & Bio
topic_mentionMTNBdiscussed_in_filing Platform & Ecosystem
topic_mentionMTNBdiscussed_in_filing Artificial Intelligence
topic_mentionMTNBdiscussed_in_filing Cybersecurity
topic_mentionMTNBdiscussed_in_filing Trusted Computing
topic_mentionMTNBdiscussed_in_filing Blockchain & Crypto
topic_mentionMTNBdiscussed_in_filing Regulation
topic_mentionMTNBdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001493152-26-014132EDGAR78K words
2025-04-152024-12-310001641172-25-004882EDGAR—
2024-03-272023-12-310001493152-24-011493EDGAR—
2023-03-152022-12-310001493152-23-007726EDGAR—
2022-03-082021-12-310001493152-22-006231EDGAR—
2021-03-292020-12-310001493152-21-006979EDGAR—
2020-03-092019-12-310001493152-20-003558EDGAR—
2019-04-012018-12-310001493152-19-004560EDGAR—
2018-03-162017-12-310001493152-18-003518EDGAR—
2017-03-312016-12-310001144204-17-018184EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001493152-25-021506EDGAR17K words
2025-08-142025-06-300001641172-25-024014EDGAR—
2025-05-152025-03-310001641172-25-011026EDGAR—
2024-11-132024-09-300001493152-24-045201EDGAR—
2024-08-142024-06-300001493152-24-032144EDGAR—
2024-05-092024-03-310001493152-24-018417EDGAR—
2023-11-082023-09-300001493152-23-039892EDGAR—
2023-08-092023-06-300001493152-23-027340EDGAR—
2023-05-102023-03-310001493152-23-016151EDGAR—
2022-11-022022-09-300001493152-22-030195EDGAR—
2022-08-112022-06-300001493152-22-021955EDGAR—
2022-05-122022-03-310001493152-22-012915EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001493152-26-015170EDGAR1K words
2026-01-230001493152-26-003445EDGAR—
2025-12-120001493152-25-027529EDGAR—
2025-11-210001493152-25-024691EDGAR—
2025-08-180001641172-25-024520EDGAR—
2025-08-060001641172-25-022445EDGAR—
2025-06-230001641172-25-016064EDGAR—
2025-05-020001641172-25-008417EDGAR—
2025-04-080001641172-25-003271EDGAR—
2025-04-040001641172-25-002818EDGAR—

219 total filings indexed. 187 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001582554
TickerMTNB
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6f7eea38696ede72b95dff4ad5de439e8343f2296e914b53520b38a7accc5141
parent: 9ea976aa248cfa21e6b37700046ab435fa86e0d46ed8a287d7402c33e180f711
content hash: 50b3b1dda04c00c777873cf79600cf8484e755125f50035f111ac1879e0141ef
signed: 2026-04-13T04:46:23.495Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf